Skip to main content
Top
Published in: BMC Complementary Medicine and Therapies 1/2023

Open Access 01-12-2023 | Research article

Chemo- and bio-informatics insight into anti-cholinesterase potentials of berries and leaves of Myrtus communis L., Myrtaceae: an in vitro/in silico study

Authors: Baydaa Abed Hussein, Isaac Karimi, Namdar Yousofvand

Published in: BMC Complementary Medicine and Therapies | Issue 1/2023

Login to get access

Abstract

Background

Myrtus communis L. (MC) has been used in Mesopotamian medicine. Here, the cholinesterase (ChE) inhibitory potential of its methyl alcohol extracts has been investigated and computationally dissected.

Method

The ChE inhibition has been measured based on usual Ellman’s colorimetric method compared to a canonical ChE inhibitor, eserine. Through a deep text mining, the structures of phytocompounds (= ligands) of MC were curated from ChemSpider, PubChem, and ZINC databases and docked into protein targets, AChE (PDB 1EVE) and BChE (PDB 1P0I) after initial in silico preparedness and binding affinity (BA; kcal/mol) reported as an endpoint. The calculation of ADMET (absorption, distribution, metabolism, excretion, and toxicity) features of phytocompounds were retrieved from SwissADME (http://​www.​swissadme.​ch/​) and admetSAR software to predict the drug-likeness or lead-likeness fitness. The Toxtree v2.5.1, software platforms (http://​toxtree.​sourceforge.​net/​) have been used to predict the class of toxicity of phytocompounds. The STITCH platform (http://​stitch.​embl.​de) has been employed to predict ChE-chemicals interactions.

Results

The possible inhibitory activities of AChE of extracts of leaves and berries were 37.33 and 70.00%, respectively as compared to that of eserine while inhibitory BChE activities of extracts of leaves and berries of MC were 19.00 and 50.67%, respectively as compared to that of eserine. Phytochemicals of MC had BA towards AChE ranging from -7.1 (carvacrol) to -9.9 (ellagic acid) kcal/mol. In this regard, alpha-bulnesene, (Z)-gamma-Bisabolene, and beta-bourbonene were top-listed low toxic binders of AChE, and (Z)-gamma-bisabolene was a more specific AChE binder. Alpha-cadinol, estragole, humulene epoxide II, (a)esculin, ellagic acid, patuletin, juniper camphor, linalyl anthranilate, and spathulenol were high class (Class III) toxic substances which among others, patuletin and alpha-cadinol were more specific AChE binders. Among intermediate class (Class II) toxic substances, beta-chamigrene was a more specific AChE binder while semimyrtucommulone and myrtucommulone A were more specific BChE binders.

Conclusion

In sum, the AChE binders derived from MC were categorized mostly as antiinsectants (e.g., patuletin and alpha-cardinal) due to their predicted toxic classes. It seems that structural amendment and stereoselective synthesis like adding sulphonate or sulphamate groups to these phytocompounds may make them more suitable candidates for considering in preclinical investigations of Alzheimer’s disease.
Appendix
Available only for authorised users
Literature
1.
go back to reference Alipour G, Dashti S, Hosseinzadeh H. Review of pharmacological effects of Myrtus communis L. and its active constituents. Phytother Res. 2014;28(8):1125–36.CrossRefPubMed Alipour G, Dashti S, Hosseinzadeh H. Review of pharmacological effects of Myrtus communis L. and its active constituents. Phytother Res. 2014;28(8):1125–36.CrossRefPubMed
2.
go back to reference Sumbul S, Ahmad, M. A, Asif, M, & Akhtar, M. Myrtus communis Linn.- A review.‏ Indian J Nat Prod Resour. 2011; 395–402. Sumbul S, Ahmad, M. A, Asif, M, & Akhtar, M. Myrtus communis Linn.- A review.‏ Indian J Nat Prod Resour. 2011; 395–402.
3.
go back to reference Scurlock J. Sourcebook for ancient Mesopotamian medicine. Society of Biblical Lit; 2014. Scurlock J. Sourcebook for ancient Mesopotamian medicine. Society of Biblical Lit; 2014.
5.
go back to reference Jamil DA. Preliminary phytochemical and screening of biocomponents by GC-MS technique in Myrtus communis L. plant flowers. AL-Qadisiyha J Pure Sci. 2016;1(21):23–33. Jamil DA. Preliminary phytochemical and screening of biocomponents by GC-MS technique in Myrtus communis L. plant flowers. AL-Qadisiyha J Pure Sci. 2016;1(21):23–33.
6.
go back to reference Tumen I, Senol FS, Orhan IE. Inhibitory potential of the leaves and berries of Myrtus communis L. (myrtle) against enzymes linked to neurodegenerative diseases and their antioxidant actions. Int J Food Sci Nutr. 2012;63(4):387–92.CrossRefPubMed Tumen I, Senol FS, Orhan IE. Inhibitory potential of the leaves and berries of Myrtus communis L. (myrtle) against enzymes linked to neurodegenerative diseases and their antioxidant actions. Int J Food Sci Nutr. 2012;63(4):387–92.CrossRefPubMed
7.
go back to reference Ellman GL, Courtney DK, Andreas V, Featherstone RM. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol. 1961;7:88–9.CrossRefPubMed Ellman GL, Courtney DK, Andreas V, Featherstone RM. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol. 1961;7:88–9.CrossRefPubMed
8.
go back to reference Berman HM, Battistuz T, Bhat TN, Bluhm WF, Bourne PE, Burkhardt K, Fagan P. The protein data bank. Acta Crystallogr D Biol Crystallogr. 2002;58:899–907.CrossRefPubMed Berman HM, Battistuz T, Bhat TN, Bluhm WF, Bourne PE, Burkhardt K, Fagan P. The protein data bank. Acta Crystallogr D Biol Crystallogr. 2002;58:899–907.CrossRefPubMed
9.
go back to reference Thomsen R. Christensen MH Mol Dock: a new technique for high–accuracy molecular docking. J Med Chem. 2006;49:3315–21.CrossRefPubMed Thomsen R. Christensen MH Mol Dock: a new technique for high–accuracy molecular docking. J Med Chem. 2006;49:3315–21.CrossRefPubMed
10.
go back to reference Dallakyan S. Olson AJ Small–molecule library screening by docking with PyRx. Methods Mol Biol. 2015;1263:243–450.CrossRefPubMed Dallakyan S. Olson AJ Small–molecule library screening by docking with PyRx. Methods Mol Biol. 2015;1263:243–450.CrossRefPubMed
11.
go back to reference Cheng F, Li W, Zhou Y, Shen J, Wu Z, Liu G, Lee PW. Tang Y Admetsar: a comprehensive source and free tool for assessment of chemical admet properties. J Chem Inf Model. 2012;52:3099–105.CrossRefPubMed Cheng F, Li W, Zhou Y, Shen J, Wu Z, Liu G, Lee PW. Tang Y Admetsar: a comprehensive source and free tool for assessment of chemical admet properties. J Chem Inf Model. 2012;52:3099–105.CrossRefPubMed
15.
go back to reference Begum S, Ali M, Gul H, Ahmad W, Alam S, Khan M, Khan MA. Ahmad M In vitro enzyme inhibition activities of Myrtus communis L. Afr J Pharm Pharmacol. 2012;6(14):1083–7. Begum S, Ali M, Gul H, Ahmad W, Alam S, Khan M, Khan MA. Ahmad M In vitro enzyme inhibition activities of Myrtus communis L. Afr J Pharm Pharmacol. 2012;6(14):1083–7.
16.
go back to reference Maggio A, Loizzo MR, Riccobono L, Bruno M, Tenuta MC, Leporini M, Falco T, Leto C, Tuttolomondo T, Cammalleri I, Bella SL. Tundis R Comparative chemical composition and bioactivity of leaves essential oils from nine Sicilian accessions of Myrtus communis L. J Essent Oil Res. 2019;31(6):546–55. https://doi.org/10.1080/10412905.2019.1610089.CrossRef Maggio A, Loizzo MR, Riccobono L, Bruno M, Tenuta MC, Leporini M, Falco T, Leto C, Tuttolomondo T, Cammalleri I, Bella SL. Tundis R Comparative chemical composition and bioactivity of leaves essential oils from nine Sicilian accessions of Myrtus communis L. J Essent Oil Res. 2019;31(6):546–55. https://​doi.​org/​10.​1080/​10412905.​2019.​1610089.CrossRef
19.
go back to reference Vellom DC, Radic Z, Li Y, Pickering NA, Camp S, Taylor P. Amino acid residues controlling acetylcholinesterase and butyrylcholinesterase specificity. Biochemistry. 1993;32(1):12–7.CrossRefPubMed Vellom DC, Radic Z, Li Y, Pickering NA, Camp S, Taylor P. Amino acid residues controlling acetylcholinesterase and butyrylcholinesterase specificity. Biochemistry. 1993;32(1):12–7.CrossRefPubMed
20.
go back to reference Taylor P. Radic Z The cholinesterases: from genes to proteins. Ann Rev Pharmacol Toxicol. 1994;34(1):281–320.CrossRef Taylor P. Radic Z The cholinesterases: from genes to proteins. Ann Rev Pharmacol Toxicol. 1994;34(1):281–320.CrossRef
21.
go back to reference Suárez D, Field MJ. Molecular dynamics simulations of human butyrylcholinesterase. Proteins Struct Func Bioinform. 2005;59(1):104–17.CrossRef Suárez D, Field MJ. Molecular dynamics simulations of human butyrylcholinesterase. Proteins Struct Func Bioinform. 2005;59(1):104–17.CrossRef
22.
go back to reference Ordentlich A, Barak D, Kronman C, Ariel N, Segall Y, Velan B, Shafferman A. Functional characteristics of the oxyanion hole in human acetylcholinesterase. J Biol Chem. 1998;273(31):19509–17.CrossRefPubMed Ordentlich A, Barak D, Kronman C, Ariel N, Segall Y, Velan B, Shafferman A. Functional characteristics of the oxyanion hole in human acetylcholinesterase. J Biol Chem. 1998;273(31):19509–17.CrossRefPubMed
23.
go back to reference Bajda M, Więckowska A, Hebda M, Guzior N, Sotrifer CA, Malawska B. Structure-based search for new inhibitors of cholinesterases. Int J Mol Sci. 2013;14(3):5608–32.CrossRefPubMedPubMedCentral Bajda M, Więckowska A, Hebda M, Guzior N, Sotrifer CA, Malawska B. Structure-based search for new inhibitors of cholinesterases. Int J Mol Sci. 2013;14(3):5608–32.CrossRefPubMedPubMedCentral
24.
go back to reference Kua J, Zhang Y, Eslami AC, Butler JR, McCammon JA. Studying the roles of W86, E202, and Y337 in binding of acetylcholine to acetylcholinesterase using a combined molecular dynamics and multiple docking approach. Protein Sci. 2003;12(12):2675–84.CrossRefPubMedPubMedCentral Kua J, Zhang Y, Eslami AC, Butler JR, McCammon JA. Studying the roles of W86, E202, and Y337 in binding of acetylcholine to acetylcholinesterase using a combined molecular dynamics and multiple docking approach. Protein Sci. 2003;12(12):2675–84.CrossRefPubMedPubMedCentral
25.
go back to reference Ali M, Muhammad S, Shah MR, Khan A, Rashid U, Farooq U, Ullah F, Sadiq A, Ayaz M, Ali M, Latif A, Ahmad M. Neurologically potent molecules from Crataegus oxyacantha; isolation, anticholinesterase inhibition, and molecular docking. Front Pharmacol. 2017;8:327.CrossRefPubMedPubMedCentral Ali M, Muhammad S, Shah MR, Khan A, Rashid U, Farooq U, Ullah F, Sadiq A, Ayaz M, Ali M, Latif A, Ahmad M. Neurologically potent molecules from Crataegus oxyacantha; isolation, anticholinesterase inhibition, and molecular docking. Front Pharmacol. 2017;8:327.CrossRefPubMedPubMedCentral
27.
go back to reference Radic Z, Gibney G, Kawamoto S, MacPhee-Quigley K, Bongiorno C, Taylor P. Expression of recombinant acetylcholinesterase in a baculovirus system: kinetic properties of glutamate 199 mutants. Biochemistry. 1992;31(40):9760–7.CrossRefPubMed Radic Z, Gibney G, Kawamoto S, MacPhee-Quigley K, Bongiorno C, Taylor P. Expression of recombinant acetylcholinesterase in a baculovirus system: kinetic properties of glutamate 199 mutants. Biochemistry. 1992;31(40):9760–7.CrossRefPubMed
28.
go back to reference Eichler J, Anselment A, Sussman JL, Massoulié J, Silman I. Differential effects of “peripheral” site ligands on Torpedo and chicken acetylcholinesterase. Mol Pharmacol. 1994;45(2):335–40.PubMed Eichler J, Anselment A, Sussman JL, Massoulié J, Silman I. Differential effects of “peripheral” site ligands on Torpedo and chicken acetylcholinesterase. Mol Pharmacol. 1994;45(2):335–40.PubMed
43.
go back to reference Picklo MJ, Olson SJ, Markesbery WR, Montine TJ. Expression and activities of aldo-keto oxidoreductases in Alzheimer disease. J Neuropathol Exp Neurol. 2001;60(7):686–95.CrossRefPubMed Picklo MJ, Olson SJ, Markesbery WR, Montine TJ. Expression and activities of aldo-keto oxidoreductases in Alzheimer disease. J Neuropathol Exp Neurol. 2001;60(7):686–95.CrossRefPubMed
Metadata
Title
Chemo- and bio-informatics insight into anti-cholinesterase potentials of berries and leaves of Myrtus communis L., Myrtaceae: an in vitro/in silico study
Authors
Baydaa Abed Hussein
Isaac Karimi
Namdar Yousofvand
Publication date
01-12-2023
Publisher
BioMed Central
Published in
BMC Complementary Medicine and Therapies / Issue 1/2023
Electronic ISSN: 2662-7671
DOI
https://doi.org/10.1186/s12906-023-04241-z

Other articles of this Issue 1/2023

BMC Complementary Medicine and Therapies 1/2023 Go to the issue